Latest News & Upcoming Events
MacuLogix Reaches New Milestone with One Million Dark Adaptation Tests
As more and more practices embrace dark adaptation testing, AdaptDx technology has become a staple in primary eye care.
Read Press ReleaseHow to Communicate and Support Patients Who Have Early AMD
Six optometrists share their tips for engaging and empowering patients in important conversations about their eye health.
Read ArticleHow to Turn AMD Awareness Month Into a Year-Round Focus
National awareness celebrations are designed to bolster the messages imparted to patients – but why stop there? Dr. Jessica Marshall shares how she combines her passions to keep the focus on AMD year-round.
Read ArticleA Step Toward Greater Success in 2022: Communicate With Retina Specialists
The new year is a typical time to reflect on current practice patterns and consider new ways to enhance practice protocols and improve patient care.
Read ArticleHow to Maximize the ROI of Dark Adaption Technology
Dr. Frances Bynum says the AdaptDx Pro has helped her catch AMD much earlier, making better patient outcomes more likely while growing her medical eyecare profitability.
Read ArticleDark Adaptation and Other New Breakthroughs in AMD Diagnosis
Recent research has shown that we may be able to identify AMD-affected individuals even earlier by testing for impaired dark adaptation. Learn how this discovery can translate to early detection and intervention of age-related macular degeneration.
Read ArticleFor William D. McPhee, Work is Fun
MacuLogix President and CEO, William D. McPhee, was recently recognized in the Central Penn Business Journal’s Power 30 for Healthcare. Bill’s leadership, visionary capabilities, and sense of humor have always been crucial points of inspiration for the team.
Read ArticleDiagnose AMD Early With Protocols
Dr. Glenn Corbin believes eye care providers can diagnose AMD early by implementing protocols that make the transition from suspicion to diagnosis smooth and pleasant for patients. Here’s the protocol used in his practice.
Read ArticleMacuLogix Establishes $25,000 Endowment for AMD Advocacy at PCO/Salus University
Our team is also donating an AdaptDx Pro to the PCO clinic in Chestnut Hill, Pa., to provide fourth-year optometry students an opportunity to utilize the latest technology before transitioning to practice.
Read ArticleThe Diagnostic Protocol Change That Transformed My Practice
Dr. Claudio Lagunas purchased two AdaptDx Pro devices to keep up with demand. This technology has transformed care in his practice while spurring profitability and allowing his team to make dark adaptation testing the norm, rather than the exception.
Read Article